|View printer-friendly version|
Demonstrates Ability to Grow Full-Thickness, 3-D Retinal Tissue
Tissue is Highly Similar to Natural Human Tissue
“We are building a pipeline of ophthalmic therapeutics that can be efficiently manufactured in a lab,” stated
More information about the 3-D retinal tissue study is available here.
BioTime common stock is traded on the NYSE MKT and TASE under the symbol BTX. For more information, please visit www.biotimeinc.com or connect with the company on Twitter, LinkedIn,